Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.
SIGA Technologies, Inc. (the “Company”) held its 2026 annual meeting of stockholders on June 9, 2026 (the “Annual Meeting”). As further described under
Item 5.07 below, at the Annual Meeting, the Company’s stockholders approved an amendment (“Plan Amendment”) to the Company’s Amended and Restated 2010 Stock Incentive Plan (the “2010 Plan”), to increase the aggregate number of shares of the Company’s
common stock, par value $0.0001 per share (“Common Stock”), authorized for issuance under the 2010 Plan by 6,500,000 shares.
A summary of the Plan Amendment is contained in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission (“SEC”)
on April 28, 2026 (the “Proxy Statement”) and the Supplement to the Proxy Statement filed with the SEC on May 8, 2026 (the “Supplement”), in connection with the Annual Meeting under the heading “PROPOSAL 4: APPROVAL OF AN AMENDMENT TO THE AMENDED AND
RESTATED 2010 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE PLAN BY 6,500,000 SHARES” and are incorporated herein by reference.
The foregoing summary is not intended to be complete and is qualified in its entirety by reference to the full text of the 2010 Plan and the Plan
Amendment, copies of which are attached as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference in this Item 5.02.
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) of the Company held on June 9, 2026, stockholders representing 62,436,105 shares
of common stock, or 87.05% of the shares of common stock outstanding as of the April 17, 2026, record date, attended or were represented by proxy. The items listed below were submitted to a vote of the stockholders who attended or were represented by
proxy, and were entitled to vote at, the 2026 Annual Meeting. Final voting results are shown below.
At the 2026 Annual Meeting, the stockholders of the Company (i) elected eight director nominees to hold office until the 2026 Annual Meeting of
Stockholders of the Company and their successors are elected and qualified and until their earlier resignation or removal, (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for
the fiscal year ending December 31, 2026, (iii) approved the non-binding advisory resolution on the compensation of the Company’s named executive officers, and (iv) approved an amendment to the 2010 Plan to increase the maximum number of shares of
Common Stock authorized for issuance under the 2010 Plan from 8,500,000 shares to 15,000,000 shares. Set forth below are the final voting results for the four proposals submitted to a vote of the stockholders.
(1) Election of the following individuals to hold office as directors of the Company for terms of one year.
Name For Withheld
──────────────────────────────────────────────────────────────
Jaymie A. Durnan 45,259,891 5,974,743
Harold E. Ford, Jr 50,828,584 406,050
General John M. Keane 50,710,136 524,498
Joseph W. Marshall, III 45,722,184 5,512,450
Gary J. Nabel, M.D., Ph. D. 46,871,987 4,362,647
Julian Nemirovsky 49,445,175 1,789,459
Diem Nguyen, Ph. D., MBA 49,884,604 1,350,030
Holly L. Phillips, M.D. 48,612,659 2,621,975
(2) Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year
ending December 31, 2026.
For Against Abstain
────────────────────────────────────────
62,040,317 343,043 52,745
(3) Approval of the non-binding advisory resolution on the compensation of the Company’s named executive officers.
For Against Abstain
──────────────────────────────────────────
48,744,042 2,404,456 86,136
(4) Approval of an amendment to the 2010 Plan to increase the maximum number of shares of Common Stock authorized for issuance under the 2010 Plan from
8,500,000 shares to 15,000,000 shares.
For Against Abstain
───────────────────────────────────────────
38,823,234 12,390,841 20,559
With respect Proposals (1), (2) and (4) there were 11,201,471 broker “non votes.”